Home/Filings/4/0001140361-17-014424
4//SEC Filing

Asterias Biotherapeutics, Inc. 4

Accession 0001140361-17-014424

CIK 0001572552operating

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:06 PM ET

Size

5.7 KB

Accession

0001140361-17-014424

Insider Transaction Report

Form 4
Period: 2017-03-30
Wirth Edward
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2017-03-30+16,92216,922 total
  • Award

    Restricted Stock Units to be settled in Common Stock

    2017-03-30+75,00091,922 total
Footnotes (1)
  • [F1]The restricted stock units vest in four equal annual installments on the first, second, third and fourth anniversaries of the grant date.

Issuer

Asterias Biotherapeutics, Inc.

CIK 0001572552

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001572552

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:06 PM ET
Size
5.7 KB